Adagene Inc.
ADAGNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $136.45M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.30$4.85
- Volume (live)
- -
- Avg. volume (3M)
- 343.96K
Adagene (ADAG) Stock Price & Financial Analysis
Adagene Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.34 - $2.55 |
|---|---|
| 52-Week High | $4.85 |
| 52-Week Low | $1.30 |
| Open | $2.42 |
| Volume (last close) | 91.20K |
| Average Volume (3M) | 343.96K |
| Revenue (TTM) | 9.42M |
|---|---|
| Net Income (TTM) | -58.99M |
| Free Cash Flow (TTM) | -53.67M |
| EPS (TTM) | −$1.50 |
| Profit Margin | -626.21% |
| Operating Margin | -689.06% |
| Return on Equity (ROE) | -55.64% |
| Debt to Equity | 0.06 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 136.45M |
|---|---|
| Shares Outstanding | 56.62M |
| Price to Sales (P/S) | 14.49 |
| Price to Book (P/B) | 1.29 |
| EV/EBITDA | -0.28 |
| 50-Day MA | $3.27 |
|---|---|
| 200-Day MA | $3.39 |
| 1-Year Change | +36.31% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Adagene at a Glance
As of the Oct 26, 2026 close, Adagene (ADAG) has a market capitalization of $136.45M. The stock trades at 14.5× sales. Over the trailing twelve months it lost $58.99M on revenue of $9.42M and burned $53.67M of free cash flow. Revenue grew 0.00% year over year.
As of its latest reported balance sheet, it holds $127.91M in cash and securities against $6.26M of debt, a net cash position of $121.65M.
Adagene does not currently pay a dividend.
The share price is up 36.3% over the past year. At $2.49 (the Oct 26, 2026 close) it sits within its 52-week range of $1.30 to $4.85, below its 200-day moving average of $3.39.
Based on 5 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $8.50, 241.4% above the Oct 26, 2026 close.
Frequently Asked Questions About Adagene
What is the current stock price for ADAG?
As of the Oct 26, 2026 close, ADAG stock trades at $2.49. The 52-week range is $1.30–$4.85, with a day range of $2.34–$2.55.
What is the P/E ratio for ADAG?
The P/E ratio (Price-to-Earnings) for ADAG is shown in the Key Statistics section. This valuation metric helps compare Adagene Inc. to industry peers.
Does ADAG pay dividends?
Adagene does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ADAG?
Based on ratings from 5 professional analysts over the last 90 days, the consensus for ADAG is Buy. The average 12-month price target is $8.50, a 241.4% upside from the Oct 26, 2026 close of $2.49.
What is the market cap of ADAG?
As of the Oct 26, 2026 close, Adagene's market capitalization is $141.0M, classifying it as a micro-cap company. Adagene operates in the Healthcare sector within the Biotechnology industry.